U.S. Department of Health & Human Services

NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Recently Added Within 3 Months Remove constraint Recently Added: Within 3 Months Subjects United States Remove constraint Subjects: United States
Number of results to display per page

Search Results

10. The Medicare preferred provider organization demonstration: overview of design, characteristics, and outstanding issues of interest

nlm:nlmuid-101193915-pdf

23. Simplifying enrollment in Medicaid and Medicare savings programs for the elderly and individuals with disabilities

nlm:nlmuid-101270426-pdf

31. State-funded home and community-based services programs for older adults

nlm:nlmuid-101513620-pdf

32. Recognizing destabilization in the individual health insurance market

nlm:nlmuid-101538593-pdf

33. Weathering the storm: the impact of the Great Recession on long-term services and supports

nlm:nlmuid-101561451-pdf

34. Employers' use of health insurance exchanges: lessons from Massachusetts

nlm:nlmuid-101596159-pdf

35. Medicare's value-based, physician payment modifier: improving the quality and efficiency of medical care

nlm:nlmuid-101598827-pdf

43. Reducing potential overuse of dementia drugs could lead to considerable savings

nlm:nlmuid-101743455-pdf

49. California's ambulatory surgery centers: a black box of care

nlm:nlmuid-101744372-pdf

54. California employer health benefits: workers shoulder more costs

nlm:nlmuid-101744473-pdf

55. Ensuring health plan mergers benefit the community: California regulators and infrastructure investment programs

nlm:nlmuid-101744523-pdf

56. California's uninsured: progress toward universal coverage

nlm:nlmuid-101744527-pdf

57. California emergency departments: use grows as coverage expands

nlm:nlmuid-101744542-pdf

58. Financing community health workers in transitions clinics

nlm:nlmuid-101744620-pdf

59. MAT in community health centers

nlm:nlmuid-101744630-pdf

63. Long-acting reversible contraceptives: a survey of Mississippi health care providers

nlm:nlmuid-101744691-pdf

65. How could the public charge proposed rule affect community health centers?

nlm:nlmuid-101744701-pdf

67. Under pressure: adults with hypertension are spending increasingly more on health care

nlm:nlmuid-101744742-pdf

68. The rising cost of specialty drugs drove spending increases for people with multiple sclerosis

nlm:nlmuid-101744756-pdf

69. Trends in primary care visits

nlm:nlmuid-101744765-pdf

70. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

nlm:nlmuid-101744770-pdf

72. Aligning services with needs: characterizing the pyramid of complexity tiering for children with chronic and complex conditions

nlm:nlmuid-101744810-pdf

75. Threading the labyrinth: why children in California with special health care needs endure delays in securing the medical equipment and supplies they need

nlm:nlmuid-101744823-pdf

77. Achieving care integration for children with medical complexity: the human-centered design approach to care coordination

nlm:nlmuid-101744833-pdf

80. Voretigene neparvovec for biallelic RPE65-mediated retinal disease: effectiveness and value : final evidence report

nlm:nlmuid-101744949-pdf

81. Chimeric antigen receptor T-cell therapy for B-cell cancers: effectiveness and value : final evidence report

nlm:nlmuid-101744954-pdf

84. Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with episodic or chronic migraine: effectiveness and value : final evidence report

nlm:nlmuid-101744957-pdf

86. Targeted immunomodulators for the treatment of moderate-to-severe plaque psoriasis: effectiveness and value : condition update : final evidence report

nlm:nlmuid-101745013-pdf

87. Inotersen and patisiran for hereditary transthyretin amyloidosis: effectiveness and value : final evidence report

nlm:nlmuid-101745015-pdf

89. Prophylaxis for hereditary angioedema with lanadelumab and C1 Inhibitors: effectiveness and value : final evidence report

nlm:nlmuid-101745056-pdf

90. Extended-release opioid agonists and antagonist medications for addiction treatment (MAT) in patients with opioid use disorder: effectiveness and value : final evidence report

nlm:nlmuid-101745061-pdf

91. Biologic therapies for treatment of asthma associated with type 2 inflammation: effectiveness, value, and value-based price benchmarks : final evidence report

nlm:nlmuid-101745064-pdf

92. Assessment and synthesis of selected Medicaid eligibility, enrollment, and renewal processes and systems in six states

nlm:nlmuid-101745975-pdf

93. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Arizona

nlm:nlmuid-101745986-pdf

94. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Colorado

nlm:nlmuid-101746005-pdf

95. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Florida

nlm:nlmuid-101746013-pdf

96. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--Idaho

nlm:nlmuid-101746022-pdf

97. Medicaid eligibility, enrollment, and renewal processes and system study: case study summary report--New York

nlm:nlmuid-101746024-pdf

98. Medicaid eligibility, enrollment, and renewal processes and systems study: case study summary report--North Carolina

nlm:nlmuid-101746028-pdf

99. Leveraging 1332 state innovation waivers to stabilize individual health insurance markets: experiences of Alaska, Minnesota, and Oregon : final report : document efforts to stabilize the individual market using state-based reinsurance

nlm:nlmuid-101746041-pdf

100. Imported seafood safety: FDA and USDA could strengthen efforts to prevent unsafe drug residues : report to the chairman, Committee on Appropriations, U.S. Senate

nlm:nlmuid-101746066-pdf